Kojima J - Search Results

1

Effect of gemfibrozil on the metabolism of pitavastatin--determining the best animal model for human CYP and UGT activities.

Fujino H, Saito T, Tsunenari Y, Kojima J. Fujino H, et al. Among authors: kojima j. Drug Metabol Drug Interact. 2004;20(1-2):25-42. doi: 10.1515/dmdi.2004.20.1-2.25. Drug Metabol Drug Interact. 2004. PMID: 15283301

2

Interaction between several medicines and statins.

Fujino H, Saito T, Tsunenari Y, Kojima J. Fujino H, et al. Among authors: kojima j. Arzneimittelforschung. 2003;53(3):145-53. doi: 10.1055/s-0031-1297087. Arzneimittelforschung. 2003. PMID: 12705168

3

Studies on the interaction between fibrates and statins using human hepatic microsomes.

Fujino H, Shimada S, Yamada I, Hirano M, Tsunenari Y, Kojima J. Fujino H, et al. Among authors: kojima j. Arzneimittelforschung. 2003;53(10):701-7. doi: 10.1055/s-0031-1299815. Arzneimittelforschung. 2003. PMID: 14650362

4

Interaction between fibrates and statins--metabolic interactions with gemfibrozil.

Fujino H, Yamada I, Shimada S, Hirano M, Tsunenari Y, Kojima J. Fujino H, et al. Among authors: kojima j. Drug Metabol Drug Interact. 2003;19(3):161-76. doi: 10.1515/dmdi.2003.19.3.161. Drug Metabol Drug Interact. 2003. PMID: 14682608

5

Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase.

Fujino H, Nakai D, Nakagomi R, Saito M, Tokui T, Kojima J. Fujino H, et al. Among authors: kojima j. Arzneimittelforschung. 2004;54(7):382-8. doi: 10.1055/s-0031-1296988. Arzneimittelforschung. 2004. PMID: 15344842

6

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase--effect of cMOAT deficiency on hepatobiliary excretion in rats and of mdr1a/b gene disruption on tissue distribution in mice.

Fujino H, Yamada I, Shimada S, Kojima J. Fujino H, et al. Among authors: kojima j. Drug Metab Pharmacokinet. 2002;17(5):449-56. doi: 10.2133/dmpk.17.449. Drug Metab Pharmacokinet. 2002. PMID: 15618696 Free article.

7

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization.

Fujino H, Yamada I, Shimada S, Yoneda M, Kojima J. Fujino H, et al. Among authors: kojima j. Xenobiotica. 2003 Jan;33(1):27-41. doi: 10.1080/0049825021000017957. Xenobiotica. 2003. PMID: 12519692

8

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans.

Yamada I, Fujino H, Shimada S, Kojima J. Yamada I, et al. Among authors: kojima j. Xenobiotica. 2003 Jul;33(7):789-803. doi: 10.1080/0049825031000121635. Xenobiotica. 2003. PMID: 12893526

9

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors.

Fujino H, Saito T, Tsunenari Y, Kojima J, Sakaeda T. Fujino H, et al. Among authors: kojima j. Xenobiotica. 2004 Nov-Dec;34(11-12):961-71. doi: 10.1080/00498250400015319. Xenobiotica. 2004. PMID: 15801541

10

Uptake mechanism of pitavastatin, a new inhibitor of HMG-CoA reductase, in rat hepatocytes.

Shimada S, Fujino H, Morikawa T, Moriyasu M, Kojima J. Shimada S, et al. Among authors: kojima j. Drug Metab Pharmacokinet. 2003;18(4):245-51. doi: 10.2133/dmpk.18.245. Drug Metab Pharmacokinet. 2003. PMID: 15618742 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters